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Abstract
Background: Precise genome editing via homology-directed repair (HDR) after double-stranded DNA (dsDNA)
cleavage facilitates functional genomic research and holds promise for gene therapy. However, HDR efficiency
remains low in some cell types, including some of great research and clinical interest, such as human induced
pluripotent stem cells (iPSCs).
Results: Here, we show that a double cut HDR donor, which is flanked by single guide RNA (sgRNA)-PAM
sequences and is released after CRISPR/Cas9 cleavage, increases HDR efficiency by twofold to fivefold relative to
circular plasmid donors at one genomic locus in 293 T cells and two distinct genomic loci in iPSCs. We find that a
600 bp homology in both arms leads to high-level genome knockin, with 97–100% of the donor insertion events
being mediated by HDR. The combined use of CCND1, a cyclin that functions in G1/S transition, and nocodazole,
a G2/M phase synchronizer, doubles HDR efficiency to up to 30% in iPSCs.
Conclusions: Taken together, these findings provide guidance for the design of HDR donor vectors and the
selection of HDR-enhancing factors for applications in genome research and precision medicine.
Keywords: CRISPR, Genome editing, Knockin, Homology-directed repair (HDR), Non-homologous end joining
(NHEJ), Donor design, 293 T, Human induced pluripotent stem cells
Background
The ability to precisely edit genomes endows scientists
with a powerful tool to interrogate the functionalities of
any pieces of DNA in the genome of any species and it
may also lead to the development of new therapies that
can potentially cure numerous genetic diseases [1–3].
However, precise gene editing by homologous recombin-
ation is very inefficient, unless a DNA double-stranded
break (DSB) is created at the targeting site, which in-
creases homology-directed repair (HDR) mediated gene
editing efficiency by ~1000-fold [4–6]. To induce DSB at
a desired site, several technologies have been developed
over the past decade, including zinc-finger nucleases
(ZFN), transcription activator-like effector nucleases
(TALEN), and the clustered regularly interspaced short pal-
indromic repeats (CRISPR)/CRISPR-associated protein-9
nuclease (Cas9) system [1]. The CRISPR-Cas9 system has
caught widespread attention due to its robust performance,
simple vector construction, and multiplexability in manipu-
lating genes [7, 8].
CRISPR is an adoptive immune system evolved in bac-
teria and archaea to fight against invading agents such as
bacteriophages or plasmids [9]. Diverse CRISPR systems
have been adapted for use in editing mammalian ge-
nomes [10–12]. Currently the most commonly used sys-
tem is derived from Streptococcus pyogenes (Sp), which
consists of a Cas9 endonuclease and two separate small
RNAs, called tracrRNA and crRNA [13], that can be
combined with a tetraloop to form a single guide RNA
(sgRNA) [14]. SpCas9, which will be referred to
* Correspondence: chengtao@ihcams.ac.cn; xzhang@llu.edu
†Equal contributors
1State Key Laboratory of Experimental Hematology, Tianjin, China
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Zhang et al. Genome Biology  (2017) 18:35 
DOI 10.1186/s13059-017-1164-8
henceforth as Cas9 for simplicity, cuts double strands of
DNA to generate blunt-ended double strand breaks
(DSBs) at 3 bp upstream of the NGG PAM (protospacer
adjacent motif ) under the guidance of sgRNA, which
specifically recognizes the chromosomal loci of interest
with 17–20 nucleotides (nt) [15, 16]. Cells repair DSBs
primarily by two mechanisms: non-homologous end
joining (NHEJ) and homology-directed repair (HDR). In
comparison to NHEJ, which generates a knockout
phenotype by introducing variable insertions or deletions
(indels) at the DSB, the HDR pathway creates precise
deletions, base substitution, or insertion of coding se-
quences of interest in the presence of a recombination
donor flanked with right and left homology arms (HA).
Thus, the HDR pathway can be exploited to facilitate
correction of diseased genes, insertion of epitope tags or
fluorescent reporters, and overexpression of genes of
interest in a site-specific manner.
Using rationally designed sgRNAs, high-level gene
knockout can be achieved in different types of cells [17–
19]. However, improving the efficiency of precise
CRISPR/Cas9-mediated gene editing or HDR-mediated
knockin (KI) remains a major challenge, especially in hu-
man induced pluripotent stem cells and primary stem
cells (iPSCs) [7, 20, 21]. Significant effort has been
devoted to increasing knockin efficiency by improving
targeting strategies, especially for insertion of a large
DNA fragment. Previous reports used ZFN, TALEN, or
CRISPR-Cas9 technology to knock in long DNA frag-
ments via a homology-independent manner [22–26]. In
these methods, the donor plasmid contains an endo-
nuclease cleavage site and can be linearized in vivo when
co-transfected with a specific endonuclease [22–26].
While these approaches are generic, they often lead to
the integration of the entire donor plasmid and may in-
duce mutagenic junctions caused by erroneous NHEJ,
limiting the application potentials.
Hisano et al. [27] modified the donor plasmid by using
short homologous sequences (20–40 bp) flanked by two
sgRNA target sequences (also known as double cut do-
nors), and observed efficient and precise integration of ex-
ogenous DNA into the predicted target locus in zebrafish.
Similarly, donor vectors harboring microhomologous DNA
ends have been used to edit human cells. However, the
HDR efficiency before drug selection was not reported,
which is likely to be less than 1% [27–29]. Longer HA is ne-
cessary for efficient HDR in human cells. It has been re-
ported that HDR of oligonucleotides is most efficient when
a single-stranded oligodeoxynucleotide (ssODN) template
with 90 nt HA is used [30]. For HDR knockin of a large
fragment, HA of ~0.2–0.8 kb have been reported to be ne-
cessary for transgene insertions and HA of up to 2 kb ex-
hibited the optimal gene targeting efficiency in human
iPSCs when a conventional circular donor is used [20].
However, no comprehensive studies have been re-
ported on the comparison of the conventional circular
plasmids and double cut donors in HDR efficiency and
on the shortest HA that is required for high-level precise
genome editing. Here we attempted to address these un-
answered questions in 293 T cells and iPSCs. We further
tested whether small molecules and other factors can
increase HDR efficiency. We found that 20–30% HDR-
mediated knockin can be achieved in human iPSCs
using double cut donors with HA of 300–600 bp in
length together with cell cycle regulators Nocodazole
and CCND1 (also known as cyclin D1).
Results
A double cut HDR donor increases HDR efficiency in
293 T cells
First, we used the most commonly used 293 T cells to
compare the two donor plasmid designs and examine
the effects of homology arm (HA) length on HDR
efficiency. To this purpose, we established a reporter
system in 293 T cells (Fig. 1a). First, we lentivirally trans-
duced 293 T cells at a low multiplicity of infection (MOI
of 0.1–0.2) with Lenti-EF1-Puro-sgRNA1-Wpre, which
contains a sgRNA1 recognition sequence between Puro
and Wpre element. After puromycin selection, we
conducted single-cell cloning and generated three 293 T
reporter lines. Following co-transfection with a promo-
terless mCherry donor plasmid and two plasmids encod-
ing Cas9 and sgRNA1, mCherry is knocked into the
target locus by HDR and the cells become mCherry+
(Fig. 1b). Although NHEJ insertion of donor may occur
in this system, these cells would remain mCherry–. As
such, the portion of mCherry+ cells detected by flow cy-
tometry (FACS) reflects HDR efficiency. We will address
NHEJ integration in later sessions.
For correcting single nucleotide polymorphisms
(SNPs) or generating precise point mutations, single-
stranded oligodeoxynucleotides (ssODNs) have been
successfully used as donor templates after creating a
DSB [30–32]. For editing large pieces, double-
stranded DNAs with relatively long HA are required
to achieve relatively high efficiency [20]. The conven-
tional donor is a circular plasmid carrying an insert
flanked by two HA. Recently, polymerase chain reac-
tion (PCR) products containing HA have also been
used as donors due to its simplicity and lack of need
for vector cloning [33, 34]. However, PCR products
were similar to conventional donor plasmids in HDR
efficiency, limiting its application potential (data not
shown).
We hypothesize that in vivo cleavable donor plasmid
can increase HDR; this can be achieved by sandwiching
the donor vector with two sgRNA recognition sequences.
When the Cas9/sgRNA complex surveys the genome and
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plasmids, it creates genomic DSB and linearizes donor
plasmids simultaneously, thus synchronizing the demand
and supply of homologous sequences and thereby increas-
ing HDR. To test this idea, we compared the HDR
efficiency using two types of donors: pD-mCherry, a con-
ventional circular HDR donor and pD-mCherry-sg, a
double cut HDR donor in which the Puro-mCherry-Wpre
cassette is flanked by two sgRNA1 recognition sequences
(Fig. 1b). In this manuscript, we tagged sg in the donor
plasmid name to distinguish it from the commonly circu-
lar donor. In the two template plasmids, Puro (663 bp)
and Wpre (592 bp) are identical and serve as left and right
HA, respectively. To simplify the naming scheme, we
unified the length of Puro and Wpre as 600 bp and tagged
a label of HA600-600 bp to the two donors to indicate
their HA length. As expected, we observed a fourfold
Fig. 1 A double cut HDR donor considerably increases HDR efficiency in 293 T cells after CRISPR-mediated DSB. a Schematic outline of the
mCherry HDR reporter system. A lentiviral vector Lenti-EF1-Puro-sgRNA1-Wpre was used to generate reporter cell line. The red triangle indicates a
sgRNA1-PAM sequence that will guide Cas9 to create DSB. 293 T cells were transduced with the lentiviral vector at a low MOI. After transduction,
cells were treated with puromycin (2 ug/mL) and single-cell cloning was conducted to generate reporter cell lines with Puro-sgRNA1-Wpre
target sequence (293 T reporter cells). EF1 is the promoter that drives the expression of a puromycin resistance gene. Wpre is the woodchuck
hepatitis virus posttranscriptional regulatory element. After co-transfection with promoterless mCherry donor and two plasmids encoding Cas9
and sgRNA1, the 293 T reporter cells use the donor to repair DSB by HDR pathway leading to the integration and expression of mCherry. b De-
sign of promoterless mCherry HDR donors. pD-mCherry is a conventional circular HDR donor and pD-mCherry-sg is a double cut HDR donor in
which the Puro-mCherry-Wpre cassette is flanked by two sgRNA1 recognition sequences. Puro (663 bp) and Wpre (592 bp) serve as left and right
HA, respectively. To simplify naming scheme, the length of Puro and Wpre are unified as 600 bp and the tag HA600-600 bp indicates their HA
length. c FACS analysis of 293 T reporter cells one week after co-transfection of Cas9 and conventional vs. double cut pD-mCherry donors, with
or without sgRNA1. The portions of mCherry+ cells represent the HDR-mediated knockin efficiencies. d HDR efficiency by two different donors.
n = 3; error bars represent S.E.M. Significance was calculated using the Student’s paired t-test: **P ≤ 0.01
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increase in the portion of mCherry+ cells with double cut
donor pD-mCherry-sg-HA600-600 bp compared to pD-
mCherry- HA600-600 bp (Fig. 1c, d).
High HDR efficiency is achieved in 293 T cells by double
cut HDR donors even with short homology arm
For conventional HDR-mediated gene targeting, many
investigators use HA lengths in the range of 0.1–2 kb
for transgene insertions when a DSB is induced at the
insertion site [20, 33, 35–42]. Having demonstrated the
superior performance of double cut HDR donor in
HDR, we decided to examine the effects of HA length
on HDR efficiency. To this purpose, we designed a series
of donors with HA in the range of 50–1500 bp in length.
All of the double cut donors contain target sequence of
sgRNA1 to flank the donor plasmids and can be linear-
ized inside cells after co-transfection with Cas9 and
sgRNA1 (Fig. 2a). As a control, we also designed a series
of conventional circular HDR donors with various HA
in the range of 300–1500 bp. We did not construct cir-
cular donors with shorter HA because HDR efficiency
was as low as 0.22% when HA is 300 bp (Fig. 2b, c and
Additional file 1: Figure S1). When HA of the circular
donors increased from 300 bp through 600–900 bp,
HDR efficiency increased to 10% (Fig. 2b, c and
Additional file 1: Figure S1).
Double cut donors increase the events of NHEJ [26],
thus the donor with 0 bp HA (pD-mCherry-sg-HA0-
0 bp) was constructed to control the events of NHEJ.
When 293 T cells were transfected with this donor, only
0.6% of cells expressed mCherry (mCherry+), suggesting
that NHEJ contributes only minimally to the percentage
of mCherry+ cells (Fig. 2b and Additional file 1: Figure
S1). This result validates the use of percentage of
mCherry+ cells as an indicator of HDR efficiency. The
HA as short as 50 bp led to a 6–10% HDR efficiency.
With the increase of HA from 50 bp through 100–
150 bp, a twofold increase in HDR efficiency was ob-
served, suggesting that optimal HA length is at least
150 bp. A further increase of HA in double cut donors
led to a gradual increase of HDR efficiency to 26%
(Fig. 2b, c and Additional file 1: Figure S1).
Taken together, the above results conducted in 293 T
cells suggest that a short HA of 300 bp in circular donor
is inefficient for HDR, whereas the same HA in double
cut donor leads to significant HDR. The double cut
donor system not only increases the HDR efficiency, but
also reduces the demand for HA length.
Enhanced HDR editing at the CTNNB1 locus in iPSCs with
double cut HDR donors
With promising results obtained in the 293 T reporter
system, we attempted to edit a human iPSC line [43],
because of its significance in regenerative medicine and
well-known difficulty in editing human iPSCs in com-
parison to 293 T cells [26]. We first chose to target
CTNNB1, a pivotal gene in the canonical WNT pathway
that is constitutively expressed in iPSCs and other cells.
We used a sgCTNNB1 to target 39 bp before the stop
codon (Fig. 3a), which showed a 60% cleavage efficiency
in iPSCs (Additional file 1: Figure S2). We then con-
structed a series of donors with GS-mNeonGreen-
Wpre-polyA sequence being flanked by HA to this locus
on both sides with various lengths (Fig. 3a, b). Silent
mutations inside the gene were introduced to prevent
cleavage in the middle of the donor by sgCTNNB1. GS
is a quadruple GGGGS linker and mNeonGreen is a
bright fluorescent protein [44]. HDR-mediated knockin
leads to the formation of a CTNNB1-mNeonGreen fu-
sion protein that fluoresces green. Similar to the above
design, we constructed a series of circular donors (pD-
mNeonGreen) with HA in the range of 150–2000 bp
and double cut donors (pD-mNeonGreen-sg) with HA
of 50–2000 bp (Fig. 3b).
As the HA length of pD-mNeonGreen donors in-
creased from 150 bp to 2000 bp, HDR efficiency at
CTNNB1 progressively increased from 0.7% to 11%
(Fig. 3b, c). In comparison, pD-mNeonGreen-sg donors
showed 4–5% HDR efficiency even with short HA of
50–100 bp. An increase of HA from 150 bp through
300–600 bp led a gradual increase of HDR from 8% to
12%. However, further elongation of HA to 1000 bp,
1500 bp, or 2000 bp in the double cut donors did not
significantly increase HDR efficiency (Fig. 3b, c). Con-
sistent with the notion that homologous recombination
depends on HA, a donor with 0 bp HA (pD-mCherry-
sg-HA0-0 bp) showed 0% HDR efficiency (Fig. 3b).
As double cut HDR donors have been used for NHEJ-
mediated knockin [26], we determined NHEJ insertion
events in this highly efficient genome editing system. Be-
sides precise editing by HDR, there are two major possi-
bilities of partial HDR and four possibilities of NHEJ
insertions (Fig. 3d). To investigate these events in bulk
iPSCs, we designed a pair of primers to specifically amp-
lify the genomic locus without amplifying donors with
HA of 50 bp, 100 bp, 150 bp, or 300 bp (Additional file
1: Figure S3). The expected amplicon length is 824 bp
for wild-type allele and 2000–4000 bp for the edited al-
lele (Fig. 3d). As expected, the first PCR gave a dominant
824 bp band and weak bands of 2000–4000 bp, which
were cut out for a second PCR. We purified and cloned
the PCR product in the size of 2000–4000 bp into pJET
vector and picked single bacterial colonies for Sanger se-
quencing (Fig. 3e).
We analyzed sequencing results from at least 30 clones
per donor with quality data at both ends (Fig. 3f,
Additional file 1: Figure S3). The majority of knockin
events were HDR, with a 77% precise insertion rate
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Fig. 2 High HDR efficiency is achieved in 293 T cells by double cut HDR donor even with short HA. a Schematic outline of pD-mCherry-sg (double
cut HDR donor) with HA in the range of 0–1500 bp in length. The red triangle indicates a sgRNA target sequence. The left arm is marked as yellow
and the right arm as blue. b Determination of the HDR efficiency by FACS. 293 T-reporter cells were analyzed one week after co-transfection of
Cas9, sgRNA1, together with either pD-mCherry or pD-mCherry-sg. The percentages of mCherry+ cells represent the HDR efficiencies. c Effects of
HA length of conventional and double cut donors on HDR efficiency. n = 3 biological replicates; error bars represent S.E.M. Significance was calcu-
lated using the Student’s paired t-test: *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; ns not significant








Fig. 3 (See legend on next page.)
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being observed with HA of 300 bp (Fig. 3f, g). Due to
limited numbers of clones that can be picked for Sanger
sequencing, we decided to quantitate the relative NHEJ
events by quantitative PCR (qPCR). We detected mul-
tiple forward backbone insertion (Fig. 3f ), which can be
used as a surrogate indicator to assess NHEJ. Primers
were designed to specifically amplify this particular
NHEJ event (Fig. 3d). The relative ratio of NHEJ/HDR
was calculated by qPCR data (which is designed to amp-
lify NHEJ insertion of plasmid backbone) divided by per-
centage of mNeonGreen+ cells (which reflects HDR
insertion) in a certain sample. With the increase of HA
from 50 bp to 300 bp, the relative NHEJ was signifi-
cantly dropped by 80%, whereas further increase of the
HA length did not lead to a further decrease in NHEJ
(Fig. 3 h), suggesting that a 300 bp homology on both
arms of double cut donors is sufficient to increase HDR
and/or suppress NHEJ.
Reducing the length of replaced sequence surrounding
DSB site enhances HDR
The above study has achieved 77% precise editing in
more than 10% of iPSCs. This HDR rate at the CTNNB1
site is lower than the PRDM14 site (see below). We no-
ticed that, in the above donor design, sequences sur-
rounding the Cas9/sgCTNNB1 cut site, 1 bp in the left
arm and 39 bp on the right arm, need to be replaced be-
fore the sequence between the two HA on the donor
can be inserted (Fig. 4a). After DSB formed, the se-
quence surrounding DSB will be used to search for the
homologous sequence, thus the replaced sequence may
be detrimental to HDR. We thus hypothesize that de-
creasing the length of replaced sequence will increase
HDR and decrease NHEJ.
To test this hypothesis, we constructed another pD-
mNeonGreen-sg of 300 bp homology. Compared to the
former pD-mNeonGreen-sg-RS1-39 bp-HA300-300 bp
(same as the donor pD-mNeonGreen-HA300-300 bp),
the right HA in the new donor pD-mNeonGreen-sg-
RS1-0 bp-HA300-300 bp extends to the cut site on
genomic DNA, making the replaced sequence (RS) to be
0 bp on the right side (Fig. 4a, b). As expected, the de-
crease of RS from 1-39 bp to 1-0 bp led to a 45% im-
provement in HDR efficiency (Fig. 4c), and knockin
pattern analysis showed that the proportion of NHEJ de-
creased from 21% to 5% (P < 0.05). Consequently, the
HDR occurrence in bulk population increased from 77%
to 88% (Fig. 4d, e, Additional file 1: Figure S4). In agree-
ment with this result, qPCR that examines backbone in-
sertion indicated a ~40% decrease in the NHEJ/HDR
ratio (P < 0.05) (Fig. 4f ).
To further validate this finding, we used 293 T re-
porter lines engineered with either a 50 bp or 200 bp se-
quence that need to be replaced on one or two arms
before HDR. As expected, HDR rate was significantly de-
creased with RS of 200 bp in one arm. When RS was
present on both arms, an up to 50% decrease in HDR
was observed (Additional file 1: Figure S5). Taken to-
gether, these results suggest that in order to achieve
high-level HDR and minimize NHEJ, two HA of the
double cut donors should be identical to the sequences
surrounding DSB.
High HDR efficiency and low NHEJ occurrence at the
PRDM14 locus by double cut HDR donor with short
homology arms
Due to heterogeneity of each locus, we asked whether
the above results can be replicated in another site. We
applied the same experimental strategy to another gene,
PRDM14, a regulator of pluripotency [45]. An
sgPRDM14 was designed to target the sequence sur-
rounding the stop codon, with cleavage site at 4 bp
downstream of the stop codon, and the cleavage effi-
ciency of this sgPRDM14 was ~30% in iPSCs (Additional
file 1: Figure S2). We designed donors to in-frame insert
2A-GFP-Wpre-ployA sequence before the stop codon,
(See figure on previous page.)
Fig. 3 Genome editing in iPSCs at the CTNNB1 locus with conventional vs. double cut HDR donors of 50–2000 bp in HA length. a Schematic of
genome editing at the CTNNB1 locus. The double strand break (DSB) is created by Cas9/sgCTNNB1 39 bp before the stop codon TAA (marked in
red). The donors contain a GS-mNeonGreen-Wpre-polyA sequence sandwiched by left HA (yellow shadow) and right HA (blue shadow). GS is a
linker. Silent mutations (lowercase and bold) were introduced to prevent cleavage by Cas9/sgCTNNB1. sgCTNNB1 sequence: bold; cut site: green
triangle; stop codon: red; backbone: lowercase. b FACS analysis of iPSCs three days after nucleofection. The percentages of mNeonGreen+ cells rep-
resent the HDR efficiencies. c Effects of HA length of conventional and double cut donors on HDR efficiency at the CTNNB1 locus. n = 4. d Sche-
matic of different knockin patterns. Apart from being edited by HDR, linearized insert sequence or backbone sequence can also integrate into the
locus through incomplete HDR (HDR at one side and NHEJ at the other side) or NHEJ. A pair of primers (red arrows) was used to amplify edited
sequence. The amplicon size is shown at the right side. For NHEJ knockin patterns, the length of PCR product is imprecise because NHEJ might
be accompanied by indels. e Procedure for knockin pattern analysis. PCR was carried out for twice. The bands between the 2000–4000 bp area
were cut off and cloned into pJET vector and individual bacterial colonies were picked for Sanger sequencing. f Summary of Sanger sequencing
results. g Distribution of different knockin patterns by double cut HDR donors with different HA lengths. h Quantitative PCR (qPCR) analysis of
donor plasmid backbone-forward insertion. y-axis indicates the relative ratio of NHEJ/HDR, in which NHEJ was calculated by qPCR data and HDR
by the percentage of mNeonGreen+ cells in a certain sample. Primers (F2 and R2) for qPCR analysis are indicated in blue in (d). n = 3. c, h Error
bars represent S.E.M. *P ≤ 0.05; **P ≤ 0.01; ns not significant, by Student’s paired t-test
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in which the 2A ribosome-skipping sequence allows for
co-translation of PRDM14 and GFP. Similar to
CTNNB1, we designed a series of circular HDR donors
and double cut HDR donors with various HA length
(Fig. 5a). A donor with 0 bp HA (pD-mCherry-sg-HA0-
0 bp) was used to control the events of NHEJ, which
showed a ~0% HDR efficiency (Fig. 5b). FACS analysis
showed that HDR efficiencies have a tendency to in-
crease along with the elongation of HA when using pD-
GFP, even though the general HDR efficiency was rela-
tively low (1–3%) (Fig. 5b, c). The pD-GFP-sg double cut
donors showed a dramatic increase in HDR efficiency
when HA length was extended from 50–100 bp (1–3%)
to 600 bp (9%) (Fig. 5b, c).
Of interest, we observed that elongation of HA from
600 bp to 1500 bp or 2000 bp led to a considerable de-
crease in HDR efficiency at the PRDM14 site (Fig. 5c),
which is in contrast to the CTNNB1 site (Fig. 3c). This
is not an artifact, because the same pattern was observed
in independent studies conducted by two experimenters
and the identities of the donor plasmids were double-
checked. This counterintuitive observation may be
unique to this site and would be a subject for future
investigation.
Fig. 4 Reducing the length of replaced sequence surrounding DSB improves HDR and reduces NHEJ. a Schematic illustration of the replaced
sequence (RS) in pD-mNEonGreen-sg-RS1-39 bp-HA300-300 bp (same as pD-mNEonGreen-HA300- 300 bp) donor. Before integration of the insert
by HDR, 1 bp in the left arm (in purple) and 39 bp on the right arm (in pink) need to be replaced. b Schematic illustration of the replaced se-
quence in pD-mNEonGreen-sg-RS1-0 bp-HA300-300 bp. Compared to the former donor, the homology in the right arm in this donor extends to
the cut site on genomic DNA, making the replaced sequence to be 0 bp on the right side. c Effects of RS length on HDR efficiency. n = 3; error
bars represent S.E.M. **P ≤0.01, by Student’s paired t-test. d Summary of Sanger sequencing results. e Distribution of different knockin patterns
when using the two donors. f qPCR analysis of donor plasmid backbone-forward insertion. n = 3; error bars represent S.E.M. *P ≤ 0.05, by Student’s
paired t-test
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Fig. 5 (See legend on next page.)
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Similar to CTNNB1, we designed two pairs of primers
to analyze knockin patterns of edited locus by donors
with HA of 50 bp, 100 bp, 150 bp, or 300 bp (Fig. 5d–f
and Additional file 1: Figure S6). We obtained high qual-
ity sequencing data of ~40 clones for each donor plas-
mid and found that as HA length increased, from 50 bp
to 300 bp, the HDR rate increased from 80% to 100%
(Fig. 5f, g). These data suggest that high-level HDR can
be achieved with double cut donor, at least for locus like
PRDM14.
We further examined the occurrence of biallelic HDR
in iPSCs. We isolated 12 GFP+ single-cell clones by
FACS sorting from the sample using pD-GFP-sg-
HA300-300 bp as the donor, as this condition provided
high HDR efficiency and low NHEJ rate (Fig. 5f, g). PCR
analysis showed one (homozygosity) or two (heterozy-
gosity) bands with expected size. The 2600-bp band in-
dicated amplification of HDR-edited allele. Among the
random picked 12 clones, 50% showed biallelic HDR
editing at the PRDM14 locus (Fig. 5 h). In all the hetero-
zygous clones, we observed indel mutations (Additional
file 1: Figure S7).
Double cut donor-mediated HDR can be further improved
by cell cycle regulators
Several small molecule compounds have been reported
to significantly improve the CRISPR-mediated HDR effi-
ciency through different mechanisms [20, 33, 46–48]
(summarized in Additional file 1: Table S1). We asked
whether these compounds can also increase HDR in our
system. We tested multiple small molecules, including
RS-1 (a stimulator of human homologous recombination
protein RAD51) [49, 50], NU7441 (a DNA-PKcs inhibi-
tor [46]), SCR7 (a DNA ligase IV inhibitor [20, 33, 49]),
Brefeldin A [47], L755507 [47, 49], and Nocodazole [48].
To draw a solid conclusion, we examined the effects on
HDR of both the CTNNB1 and PRDM14 locus using the
verified highly efficient pD-sg-HA300-300 bp double cut
donor. We added small molecules at their optimal con-
centration after nucleofection and changed the medium
24 h later. HDR efficiency was analyzed on day 3 by
FACS. RS-1, SCR7, and L755507 did not show signifi-
cant improvement in HDR efficiency at both the
PRDM14 and CTNNB loci, while Nu7441 and Brefeldin
A showed a less pronounced improvement only at the
CTNNB locus (P < 0.05). In contrast, treatment with
Nocodazole, which synchronizes cell cycle at G2/M
phase, increased HDR efficiency by ~50% at both loci
(P < 0.001) (Fig. 6a). Similar results were observed in
H1 the human ES cell line (Additional file 1: Figure
S8), demonstrating the reproducibility of this finding.
We also examined the effects of overexpression of
RAD51, a key factor in the homologous recombination
pathway, and Ad4E1B-E4orf6, which were reported to
considerably increase HDR by inhibiting NHEJ [51]. In
contrast to expectations, RAD51 or Ad4E1B-E4orf6 sig-
nificantly decreased HDR efficiency in our system (P <
0.001), at the two loci (Fig. 6b). Encouraged by the
HDR-enhancing effects of Nocodazole, we tested
CCND1, also known as cyclin D1, which induces cell
cycle transition from G0/G1 to S-phase [52]. CCND1
showed a ~20% improvement in HDR at both sites
(Fig. 6b). We further applied Nocodazole and CCND1
together and found that they had an additive effect and
increased HDR efficiency by 80–100% at both loci
(Fig. 6c). This observation may be explained by that the
combined use of CCND1 and Nocodazole increases cells
in S/G2/M phases during which HDR is efficient, while
they considerably decrease cells in G0/G1 phase during
which double-stranded DNA (dsDNA) breaks are pre-
dominated repaired by NHEJ. As such, Nocodazole and
CCND1 have an additive effect on enhancing precise
genome editing.
Last, we asked whether increased HDR by CCND1
may lead to decreased NHEJ. We only tested the
CTNNB1 locus, as using a 300 bp homology at PRDM14
already decreased NHEJ to a very low level. We used the
optimized double cut donor pD-mNeonGreen-sg-RS1-
0 bp-HA300-300 bp, which still showed an appreciable
NHEJ rate. However, after co-transfection of iPSCs with
(See figure on previous page.)
Fig. 5 High HDR efficiency at the PRDM14 locus is achieved by double cut HDR donor with short HA. a Schematic of genome editing at the PRDM14
locus. An sgPRDM14 was designed to create DSB at 4 bp after the stop codon TAG (marked in red). The donors contain a 2A-GFP-Wpre-polyA se-
quence sandwiched by left HA (marked in yellow shadow) and right HA in blue shadow. The PRDM14 and GFP open reading frames (ORF) are fused by
a ribosome skipping sequence 2A. pD-GFP is a conventional circular HDR donor and pD-GFP-sg is a double cut HDR donor flanked with the sgPRDM14
target sequence. sgPRDM14 sequence: bold; cut site: red triangle; plasmid backbone: lowercase. b Determination of HDR by FACS. iPSCs were analyzed
three days after nucleofection of Cas9, sgPRDM14 together with either pD-GFP or pD-GFP-sg. The percentages of GFP+ cells represent the HDR effi-
ciencies. c Effects of HA length of conventional and double cut donors on HDR efficiency at the PRDM14 locus. n = 4; error bars represent S.E.M. *P≤
0.05; **P≤ 0.01; ***P≤ 0.001; ns not significant, by Student’s paired t-test. d Schematic of different knockin patterns. Apart from being edited by HDR,
cells could also be integrated with linearized inert sequence or backbone sequence through incomplete HDR or NHEJ. Two pairs of primers were de-
signed to amplify the edited locus. The amplicon size is listed at the right side. e Procedure for knockin pattern analysis. PCR was carried out twice. The
bands between the 2000–4000 bp area were cut off and cloned into pJET vector and individual bacterial colonies were picked for Sanger sequencing.
f Summary of Sanger sequencing results. g Distribution of different knockin patterns by double cut HDR donors. h Determination of monoallelic vs.
biallelic HDR by donor pD-GFP-sg-HA300-300 bp. Twelve edited clones were analyzed
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CCND1 and HDR plasmids, the NHEJ events were de-
creased from 12% to 3% (Fig. 6d–f ). These data suggest
that cell cycle regulators not only increase HDR but also
suppress NHEJ.
High HDR efficiency in human iPSCs using this ap-
proach will find its way to diverse applications. Take
one, after tagging a gene of interest with a flexible G4S
linker and a fluorescent protein gene, a fusion protein
will be formed, which can be used to quantitate the gene
expression level by FACS and map its cellular
localization by confocal microscopy. Here we targeted
mNeonGreen to the stop codon of CTNNB1 and tdTo-
mato to the stop codon of PRDM14 and examined the
cells by confocal microscopy. As expected, the
PRDM14-tdTomato fusion protein was localized in the
nucleus (Additional file 1: Figure S9a). Of interest, we
observed the mNeonGreen signal on plasma membrane,
indicating that CTNNB1 is largely localized at iPSC
membrane (Additional file 1: Figure S9b).
Discussion
Here we report that a double cut donor vector design
together with the cell cycle regulators leads to high-level
HDR-mediated precise integration of a 2-kb piece of
DNA in iPSCs. We show that the double cut donor with






Fig. 6 Regulating cell cycle further improves HDR efficiency of the double cut donor system. a The effects of small molecules on HDR efficiency
at the CTNNB1 or PRDM14 locus. The iPSCs were treated with RS-1 (10 μM), Nu7441 (2 μM), SCR7 (1 μM), Brefeldin A (0.1 μM), L755507 (5 μM),
or Nocodazole (100 ng/mL) at 0–24 h after nucleofection and the HDR efficiency was determined by FACS on day 3. b The effects of RAD51,
Ad4E1B-Eorf46, and CCND1 on HDR efficiency at the CTNNB1 or PRDM14 locus. The plasmid encoding RAD51, Ad4E1B-Eorf46, or CCND1 was co-
transfected with Cas9, sgRNA, and pDonor. The HDR efficiency was examined by FACS on day 3. c The effects of Nocodazole and CCND1 on HDR
efficiency at the CTNNB1 or PRDM14 locus. The plasmid encoding CCND1 was co-transfected with Cas9, sgRNA, and donor plasmid. Nocodazole
(100 ng/mL) was added into the medium at 0–24 h after transfection. HDR efficiency was determined by FACS on day 3. a–c Comparison with
control by Student’s paired t-test: *P≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; ns not significant. d–f CCND1 increases HDR rate at the CTNNB1 locus. The
procedure for knockin pattern analysis was detailed above. At least 30 colonies were picked for Sanger sequencing at both ends
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sequences leads to a twofold to fivefold increase in HDR
efficiency compared to the circular donor plasmid. The
optimal HA length of double cut donors for achieving
high-level HDR is 600 bp and further elongation only
slightly increases or even decreases HDR at different
sites. Minimizing the replaced sequence surrounding the
DSB increases HDR and suppresses NHEJ-mediated in-
sertion. The combined use of cell cycle regulators
Nocodazole and CCND1 leads to an additional 100% in-
crease in HDR efficiency. After optimization, less than
3% NHEJ-mediated insertion of donor plasmid sequence
can be detected. These findings should have important
implications for precision medicine.
The length of HA is the most critical factor for target-
ing template design. For precise editing of point muta-
tions or SNPs, ssODNs are often used as a DNA
template and homology of 30–70 bases on either arm is
sufficient for high-level HDR [30, 53]. However, precise
editing, in particular insertion of a large piece, remains
inefficient in cells of significant research and clinical
interest, such as human pluripotent stem cells. In early
gene targeting studies, the homology of the two arms
was recommended to be 5–8 kb in total and more than
1 kb for the shorter arm. After the advent of artificial
nuclease and CRISPR technologies, HA lengths ranging
from 100 bp to several kbp have been used for successful
gene editing [20, 33, 40–42]. The optimal HA length is
reported to be 2 kb, at least in human iPSCs [20]. We
reasoned that simultaneous cleavage of the genomic
and plasmid DNA makes the HA more accessible,
thus the optimal HA might be shorter. To identify
the optimal HA length, we evaluated the homology
length in the range of 50–2000 bp at two to three
distinct loci. The shortest length we tested is 50 bp,
because 40–50 bp HA have been previously used by
other investigators [27, 34, 54].
Using stringent promoterless donor HDR reporter sys-
tems, we systematically compared conventional circular
HDR donors with double cut HDR donors. We con-
structed donors to insert florescent transgenes into each
target locus, so that HDR events can be detected by
FACS after precise transgene knockin. Since HDR effi-
ciency differs from one site to another, we studied three
sites. We observed that the effects of HA length on
HDR efficiency is not identical for the three sites. How-
ever, careful examination of our data leads to several
conclusions. First, for conventional circular HDR donor,
a HA of less than 150 bp is insufficient to guide precise
genome editing. An increase of HA from 300 bp to
2000 bp shows a trend of continued increase in HDR ef-
ficiency. This is consistent with a previous report show-
ing an optimal HA length of 2000 bp in iPSCs [20].
Second, HA as short as 50 bp in the double cut donor
design lead to appreciable HDR, whereas elongation of
HA to 150 bp considerably increases HDR efficiency.
The highest HDR is achieved when HA is 600–1000 bp
in length. Third, the use of double cut donor increases
HDR efficiency by twofold to fivefold compared to circu-
lar plasmid donor. We noted that the optimal HA length
is very similar to the DNA length dependence of the
single-strand annealing (SSA) pathway in Saccharomyces
cerevisiae, the budding yeast [55], suggesting that the
DSB in our system is most probably repaired by the SSA
pathway. This may also explain why most HA enhancers
and NHEJ inhibitors do not show positive effects on
HDR in our study.
Taking all factors into consideration, we recommend
the use of 600 bp HA for double cut donor vector de-
sign, for the following reasons. First, 600 bp is the opti-
mal length for some sites and further increases in HA
length only slightly enhances HDR at some locus, while
a HA with more than 1000 bp may be even detrimental
for some locus. Second, construction of donor vector
with two 600 bp homology arms is an economical
choice, because PCR amplification of short pieces from
the genomic DNA (gDNA) template is very efficient. In
addition, the vector verification can be easily conducted
by Sanger sequencing, which usually provides quality
data of 700–800 bp.
In our study, we used one sgRNA to target both gDNA
and the donor plasmid. In previous studies, two sgRNAs
were used, one for creating genomic DSB and another
for releasing donor template from the plasmid [26, 27].
This design increases complexity and occasionally may
not be able to perfectly synchronize the demand and
supply of homologous sequences, because the cleavage
efficiencies of the two distinct sgRNAs may not be iden-
tical. In support of this hypothesis, we found that the
use of two sgRNAs in the double cut donor system de-
creases HDR by ~10%, albeit no significant difference is
achieved (Additional file 1: Figure S10).
Another consideration for donor template design is
the distance of the insertion locus from the DSB, which
should be as short as possible and 100–200 bp away,
might decrease the knockin efficiency by ~80% when a
conventional donor plasmid is used [37]. In the double
cut donor system, a 50–100 bp replaced sequence leads
to a 50% decrease in HDR efficiency in 293 T cells
(Additional file 1: Figure S5). Similarly, a 39 bp replaced
sequence at the CTNNB1 locus induces a 30% decrease
in HDR in iPSCs (Fig. 4c). As such, the ideal donor
should be designed to have two HA identical to se-
quences surrounding DSB created by Cas9/sgRNA.
We also investigated whether commonly used HDR
boosters can improve knockin efficiency in our system.
Thus far, several compounds have been reported to be
able to improve knockin efficiency. Suppression of the
NHEJ key enzymes such as DNA Ligase or DNA PK has
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been shown to stimulate Cas9-mediated HDR at the ex-
pense of NHEJ [20, 33, 46]. NU7441, an inhibitor of
DNA-PKcs, increases the knockin efficiency by twofold
in 293 T cells [46]. SCR7, an inhibitor of DNA ligase IV,
improves the knockin efficiency by twofold to 19-fold in
two reports [20, 33]. Brefeldin A and L755507 increase
HDR twofold to threefold in mouse pluripotent stem
cells [47]. In addition, RS-1, which upregulates homolo-
gous recombination factor RAD51 [56], increases
nuclease-mediated knockin efficiency by twofold to five-
fold [49, 50]. In contrast to these reports, none of these
molecules consistently enhances HDRs at both CTNNB1
and PRDM14 loci in human iPSCs. In further support of
these results, we found that overexpression of RAD51 or
Ad4E1B-E4orf6, which degrade ligase IV, is detrimental
to HDR (Fig. 6b). One explanation for the discrepancy
between our results and the published data is that our
optimized vector has achieved high-level HDR, which
masks the subtle changes mediated by many inhibitors.
Alternatively, the effects of these factors are cell line
dependent. In support of this notion, unimpressive ef-
fects of SCR7 and L755507 were also reported in recent
publications using different cell lines or cells from differ-
ent species [49, 50].
Another strategy to enhance HDR takes advantage of
the fact that NHEJ occurs during the G1, S, and G2
phases, whereas HDR-mediated repair is restricted to
the late S and G2 phases [57, 58]. Timed delivery of
Cas9 protein and sgRNAs into cells arrested at the G2/
M phase after Nocodazole treatment significantly in-
creases HDR events [48]. We found that cell cycle
synchronization with Nocodazole in our plasmid Cas9/
sgRNA system can increase HDR efficiency by ~50%
(Fig. 6a and Additional file 1: Figure S8). In addition,
CCND1 increases HDR by ~20%, which may take effect
by pushing cells at G1 phase into the S phase. Moreover,
Nocodazole synergizes with CCND1 to increase HDR ef-
ficiency by ~100%. The additive effect is due to Nocoda-
zole synchronizing the cell cycle at the G2/M phase and
to CCND1 inducing cell cycle transition from the G0/
G1 to the S phase, leading to more cells in the S/G2/M
phases during which dsDNA breaks are preferentially
repaired by HDR instead of NHEJ. Similar strategies
have been used to increase HDR and decrease NHEJ in-
cidence by creating a fusion protein of Cas9 and a pep-
tide from Geminin, which is expressed during S/G2/M
and degraded during G1 [59, 60]. However, this ap-
proach may occasionally decrease HDR due to decreased
Cas9 protein levels. The use of CCND1 is preferable, be-
cause it enhances HDR as well as decreases NHEJ inser-
tion. Alternatively, integration of all these strategies may
lead to enhanced precise genome editing.
HDR efficiency in human pluripotent stem cells, in-
cluding iPSCs or embryonic stem cells, is often much
lower than other types of cells [61]. Approximately 1%
or lower HDR efficiency is generally achieved after
inducing DSB [21, 42, 62, 63], although an up to 11% ef-
ficiency has been reported, which might be cell line
dependent and is limited to homozygous gene replace-
ment [20]. Using the double cut HDR donor, we
achieved ~14% HDR at CTNNB1 and ~10% at PRDM14.
Combined use of Nocodazole and CCND1 further in-
creases the HDR efficiency to 20–30%. Given that iPSCs
have been widely used for disease modeling and regen-
erative medicine, this improvement will ease the burden
for identification of correctly edited cells by single-cell
cloning and sequencing.
Recently, ribonucleoproteins (RNPs), the Cas9 protein
in complex with in vitro transcribed guide RNA, have
been used together with a single-stranded oligonucleotide
HDR template for nucleotide replacement or insertion
[48, 64, 65]. Moreover, chemically modified guide RNAs
can further enhance genome editing efficiency [66]. We
believe that the double cut donor vector can also be deliv-
ered together with Cas9 protein/RNA and sgRNA tran-
scripts, which may even be preferable in applications such
as zygote injection for creating knockin animals.
Conclusion
In summary, synchronizing the demand and supply of
homologous sequences, by flanking the targeting vector
with two sgRNA recognition sites that are identical to
the sgRNA target site on the genome, leads to a twofold
to fivefold increase in HDR-mediated knockin. The
double cut donor template design requires HA as short
as 600 bp to enable high-level precise insertion of a
large piece of DNA. We believe that the improved tar-
geting strategies are broadly applicable in generating
precise knockin or reporter animals and human cell
lines for basic research and disease modeling. Further
improvements of the double cut donor system may




The complementary DNA (cDNA) for a puromycin re-
sistant gene (Puro) was amplified by PCR and purified
using KAPA HiFi polymerase (KAPA Biosystems) and a
GeneJET Gel Extraction Kit (Thermo Fisher Scientific),
respectively. The open reading frame of the Puro gene
was inserted into a lentiviral vector with the EF1
promoter, used to drive the expression of Puro. The
sgGFP target sequence together with the NGG PAM
(GGTGCAGATGAACTTCAGGG) was in-frame PCR-
cloned into the vector by incorporating the relevant se-
quences in the primers. To construct vectors with the
GFP gene between the Puro and Wpre element, while
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still harboring sequences surrounding DSB that are non-
homologous to the targeting vector, a ~50 bp or
~200 bp irrelevant sequence was introduced between
the sgRNA1 recognition sequence and the Puro and/or
Wpre element. Multiple gene inserts were cloned into
lentiviral vector backbones using the NEBuilder HiFi
DNA Assembly Kit (New England Biolabs), following
manufacturer’s instructions. All constructs were verified
by Sanger sequencing (MCLAB). Correct clones were
grown in CircleGrow Media (MP Biomedicals) and DNA
plasmids were purified using Endo-Free Plasmid Maxi
Kits (Qiagen). A standard calcium phosphate precipita-
tion protocol was used for lentivirus production as pre-
viously described [32]. The lentiviral vectors were
concentrated a 100-fold by centrifugation at 6000 g for
24 h at 4 °C to reach titers of 2–10 × 107/mL.
GFP reporter cell line
Human embryonic kidney (HEK) 293 T cells were trans-
duced with lentiviral vectors (Lenti-EF1-Puro-GFP-Wpre,
Lenti EF1-Puro-sgRNA1-Wpre; Lenti EF1-Puro-GFP(nh0-
200 bp)-Wpre, Lenti EF1-Puro-GFP(nh200-0 bp)-Wpre,
Lenti EF1-Puro-GFP(nh50-50 bp)-Wpre, and Lenti EF1-
Puro-GFP(nh200-200 bp)-Wpre) at a low MOI of 0.1–0.2,
and stably transduced cells were selected for by supple-
menting culture medium with 1 μg/mL puromycin. After
one week of antibiotic selection, cell lines expressing puro-
mycin resistance and either high GFP (>98%) or no GFP
production (in cases of GFP fragments or no GFP insert)
were established.
sgRNA design
The CHOPCHOP website (https://chopchop.rc.fas.harvard.
edu/) was used to design high-performance sgRNAs target-
ing various positions on GFP sequence and the stop codons
of the human CTNNB1 and the human PRDM14 genes
[67]. We preferentially chose sgRNAs with a G at the 5′
end which initiates U6-promoter-mediated transcription





which sgRNA1, sgRNA2, and sgRNA3 do not target hu-
man genome.
Cas9 and sgRNA plasmid construction
All Cas9 and sgRNA plasmids were constructed with a
NEBuilder HiFi DNA Assembly Kit (New England Bio-
labs). First, PCR products were produced using KAPA
HiFi polymerase (KAPA Biosystems) and purified using
a GeneJET Gel Extraction Kit. The linear PCR products
were then assembled into plasmids in a DNA assembly
reaction (20 uL), on ice, according to the manufacturer’s
instructions. The reaction contained NEBuilder HiFi
DNA Assembly Master Mix (10 uL), equal ratios of PCR
products (0.2–0.5pmols), and deionized water. The
ligation reaction was briefly vortexed and centrifuged
prior to incubation at 50 °C for 5–30 min. NEB 5-alpha
Competent E. coli cells were then transformed with the
assembled DNA products and plated on ampicillin-
treated agar plates. Multiple colonies were chosen for
Sanger sequencing (MCLAB) to identify the correct
clones using the primer U6-F: GGGCAGGAAGAG
GGCCTAT.
Donor plasmid construction
All of the donor plasmids used in this study were gener-
ated with a CloneJET PCR Cloning Kit (Thermo Scien-
tific). To construct pJET donor plasmids, the homology
repair templates were amplified by PCR using KAPA
HiFi polymerase (KAPA Biosystems) and purified using
a GeneJET Gel Extraction Kit. To clone donor plasmids
harboring sgRNA recognition sites, the sgRNA target se-
quence together with a PAM (NGG) was included in
both the forward and the reverse primers. A ligation re-
action (20 uL) was performed, on ice, according to the
manufacturer’s instructions, containing 2X Reaction Buf-
fer (10 uL), pJET1.2/blunt Cloning Vector (50 ng/μL) (1
uL), T4 DNA Ligase (1 uL), purified PCR product (0.15
pmol), and nuclease-free water (remaining volume). The
ligation reaction was then briefly vortexed and centri-
fuged prior to incubation at room temperature (22 °C)
for 5–30 min. NEB 5-alpha Competent E. coli cells were
then transformed with the ligation product and plated
on ampicillin-treated agar plates. Multiple colonies were
chosen for Sanger sequencing (MCLAB) to identify the
correct clones using the primers pJET1.2-F: CGACT
CACTATAGGGAGAGCGGC and pJET1.2-R: AAGAA
CATCGATTTTCCATGGCAG. Correct clones were
cultured and DNA plasmids were purified, as previously
described. To construct donor plasmid targeting
CTNNB1 at 39 bp before the stop codon, the left and
right HA were amplified from human genomic DNA;
with the stop codon being removed and in-frame linked
with the GS sequence (a quadruple of GGGGS peptides);
the insert mNeonGreen-Wpre-polyA was amplified from
another vector in the lab. A sgCTNNB1 target sequence
together with the PAM sequence (GCTGATTGCTGT
CACCTGGAGG) was tagged at a location outside of the
two HA. To construct donor plasmids targeting the
PRDM14 stop codon, the left and right HA were ampli-
fied from human genomic DNA, with the stop codon
being removed and in-frame linked with the 2A se-
quence; the insert 2A-GFP-Wpre-polyA was amplified
from another vector in the lab. A sgPRDM14 target se-
quence together with the PAM sequence (GGAAGAC-
TACTAGCCCTGCCAGG) was tagged to the regions
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flanking the upstream and downstream HA. The
CTNNB1 and PRDM14 donor template plasmids were
generated with a NEBuilder HiFi DNA Assembly kit
(New England Biolabs), as previously described.
Construction of putative HDR-enhancing plasmids
To test if extra factors can enhance double cut donor me-
diated HDR, we examined RAD51, CCND1 (Cyclin D1),
and Ad4 E1B55K and E4orf6 [51]; the latter two genes
were linked together using a ribosome-skipping E2A se-
quence. cDNAs for RAD51 and CCND1 were purchased
from DNASU, and Ad4 E1B and E4orf6 were purchased
from Addgene (Plasmid #64218 and 64222). The EF1 pro-
moter was used to drive the expression of these genes and
the Wpre-polyA cassette was tagged downstream of the
stop codon to increase transgene expression levels. All
vectors were confirmed by sequencing.
Cell culture
HEK 293 T cells were cultured in DMEM (Dulbecco’s
modified Eagle medium) supplemented with 10% fetal
bovine serum (FBS; ABM) and 1% penicillin/strepto-
mycin. Human iPSCs used in this study were generated
from peripheral blood mononuclear cells after lentiviral
transduction of five reprogramming factors [43]. Feeder-
free iPSCs were maintained on Matrigel-coated plates
(BD) and cultured in mTeSR1 (Stemcell Technologies)
according to the manufacturer’s instructions. The ROCK
inhibitor Y-27632 (10 μM, Millipore) was added to the
culture medium before, during, and after, passaging with
Accutase. All cells were cultured at 37 °C with 5% CO2.
Transfections
For transfection of HEK 293 T cells, Lipofectamine 3000
(Life Technologies) was used according to manufac-
turer’s instructions. For transfection of human iPSCs,
cells were electroporated using the Lonza Nucleofector
system (Lonza). The Human Stem Cell Nucleofector® Kit
2 and the program B016 were used as outlined in the
manufacturer’s instructions. For nucleofection, 1 μg of
each plasmid was used.
T7E1 cleavage assay
iPSCs were nucleofected with either sgCTNNB1 or
sgPRDM14 together with Cas9 plasmid. Three days later,
genomic DNA was isolated using the DNeasy Blood &
Tissue Kit (Qiagen) according to the manufacturer’s in-
structions. For cells targeted with sgCTNNB1, the pre-
dicted flanking sequence was PCR-amplified using
CTNNB1-F1 and CTNNB1-R1 primers; for cells treated
with sgPRDM14, PRDM14-F2 and PRDM14-R2 primers
were used. The amplicons were denatured by heating
and annealed to form heteroduplex DNA, which was
treated with 5 units of T7 endonuclease 1 (New England
Biolabs) for 20 min at 37 °C and then analyzed by 2%
agarose gel electrophoresis. The cleavage frequency was
calculated from the proportion of cut bands intensity to
total bands intensity.
Small molecules
To test the effect of small molecule compounds, iPSCs
were evenly split into eight wells after nucleofection with
Cas9/sgRNA and the relevant double cut donor. DMSO
control (0.1%), RS-1 (10 μM), Nu7441 (2 μM), SCR7
(1 μM), Brefeldin A (0.1 μM), L755507 (5 μM), Nocoda-
zole (100 ng/mL), or Nu7441 (2 μM) and SCR7 (1 μM)
were added in the wells for the first 24 h and then the
medium was changed with fresh medium thereafter.
Three days after nucleofection, cells were harvested
for FACS analysis to determine the HDR efficiency in
each condition.
Flow cytometry
To determine the percentage of cells that are mCherry-
positive, mNeonGreen-positive, or GFP-positive (Knockin
by HDR), cells were disassociated with Accutase and ana-
lyzed on a BD FACSAria III flow cytometer. Cells were
first gated for the intact cell population using forward
scatter versus side scatter plots and then gated for single
cells based on forward scatter W versus forward scatter H.
The means and standard errors from at least three inde-
pendent experiments were calculated and statistical sig-
nificance was determined using the student’s paired t-test.
Determination of NHEJ-mediated and HDR-mediated
knockin by PCR and Sanger sequencing
Human iPSCs were harvested at day 3 after co-
transfection of Cas9/sgRNA and donors for DNA extrac-
tion. The CTNNB1 and PRDM14 target sequences were
amplified with KAPA HiFi DNA polymerase by PCR
twice. For the first-round PCR at CTNNB1 locus,
CTNNB1 forward primer-F1 (GTGGCCTGGCACTG
AGTAAT) and CTNNB1 reverse primer-R1 (CTCAG-
CAACTCTACAGGCCA) were used with the PCR cyc-
ling condition being 98 °C for 5 min, followed by 98 °C
for 5 s, 68 °C for 1 min for 30 cycles. The bands in the
size range of 2–4 kb were cut out and purified using the
GeneJET Gel Extraction Kit. For second-round PCR,
1 ng of purified primary PCR products was amplified
using the same pair of primers and cycling conditions.
The bands in the range of 2–4 kb from the second PCR
were purified and cloned into the pJET vector. Approxi-
mately 50 individual bacterial colonies from each condi-
tion were picked for Sanger sequencing. Clones with
high-quality sequencing data at both ends were aligned
with expected HDR knockin sequence and donor plas-
mid sequence by BLAST. Clones with wild-type gDNA
insertion were reported. Similar procedure was carried
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out for the PRDM14 locus with PRDM14 forward primer-
F1 (CCAGCCTGCAATCTGCTTTT) and PRDM14 re-
verse primer-R1 (gccAACTGCAGGGACTTCTA) for the
first-round PCR and PRDM14 forward primer-F2 (GACC
AGGAGTGCTCTATGGC) and PRDM14 reverse primer-
R2 (AGGAAATAGAGAGAATCCGAATCTC) for the
second-round PCR. The annealing temperature of 64 °C
was used for both first-round and second-round PCR.
Examination of relative incidence of NHEJ-mediated
donor plasmid insertion
To quantitate the occurrence of NHEJ-mediated inser-
tion of large pieces from donor plasmid, we conducted
qPCR. We used one possible insertion, backbone-
forward insertion, as a surrogate indicator of all the
possible NHEJ-mediated insertion of donor plasmid. The
real-time PCR reaction system (20 μL) consisted of
10 μL of SYBR Green qPCR Master Mix (2X), 1 μL each
of F2 (qPCR-BB-forward primer2, CACTCATTAGG
CACCCCAGG) and R2 (qPCR-gDNA-reverse primer2,
CCCACCCTACCAACCAAGTC), and 100 ng gDNA
from a cell sample from day 3. The cycling conditions
were 95 °C for 3 min, followed by 95 °C for 15 s, 64 °C
for 20s, and 72 °C for 30s, for 35 cycles. The GAPDH
gene, a housekeeping gene, was used to normalize the
qPCR data. The relative NHEJ incidence was calculated
by the relative value of backbone-forward insertion di-
vided by portion of HDR in the same sample.
Single-cell cloning and genotyping of edited iPSCs
Human iPSCs were dissociated using Accutase in order
to get single-cell suspension. Live iPSCs were suspended
in Accutase and did the following single-cell sorting as
soon as possible. Single-cell sorted using a BD FACSAria
III with a 70 mm nozzle under sterile conditions into
96-well plates coated with Matrigel. Each well contained
mTeSR medium as well as the ROCK inhibitor Y-27632
(10 μM). After sorting, plates were cultured at 37 °C
with 5% CO2. Colony formation was seen seven days
post sorting. The cells were refreshed with mTeSR
medium every two to three days.
96-well cells were dissociated using EDTA and trans-
ferred into 24-well plates 14 days after FACS. Two or
three days later, part of the cells were harvested for
DNA extraction using a Genomic DNA Extraction Kit
(Qiagen) and the remaining cells were passaged for flow.
GFP and PRDM14 sequence was amplified with KAPA
HiFi DNA polymerase by PCR using the following
primers: PRDM14-HA300KI-F: GACCAGGAGTGCTC
TATGGC, PRDM14-HA300KI-R: AGGAAATAGAGA
GAATCCGAATCTC. The PCR cycling conditions were
95 °C for 4 min followed by 98 °C for 5 s, 64 °C for 15 s,
72 °C for 3 min, for 35 cycles.
Confocal microscopy
Cover glass was coated with 0.1% geltin for 30 min at
37 °C and then coated with Matrigel. iPSCs were seeded
on cover glass and cultured for two days. Two days later,
the cells with mNeonGreen fused in frame to the C-
terminus of CTNNB1 were stained with Hoechst 33258
(Sigma) and Cell Mash Deep Red (Life Technology) fol-
lowing the protocol. iPSCs with tdTomato fused in
frame to the C-terminus of PRDM14 were fixed with 4%
paraformaldehyde (Sigma), followed by staining with
Phalloidin 488 (Thermo Fisher Scientific) and DAPI
(Sigma). Images were taken using a Zeiss Axio Observer
Z1 inverted LSM 710 NLO laser scanning confocal
microscope. Different lasers were used to excite each
dye. Hoechst 33258 and DAPI were excited with a 405-
nm DPSS laser, mNeonGreen and Phalloidin 488 were
activated with the 488-nm line of a Kr-Ar multiple laser,
and CellMask Red and tdTomato with a 633-nm HeNe
laser. For Hoechst 33258 and DAPI, emitted light was
collected at 417–679 nm using a PMT array. For
mNeonGreen and Phalloidin, emitted light was collected
with a single PMT at 493–630 nm. For CellMask Red
and tdTomato, emitted light was collected with a single
PMT at 638–755 nm.
Statistics
Data were analyzed by student’s paired t-test for two
groups and ANOVA for more than two groups. Clone
difference between different groups was analyzed by
Fisher’s exact test. All the values were shown as mean ±
SEM (standard error of the mean).
Additional file
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